CD133 Is Associated with Increased Melanoma Cell Survival after Multikinase Inhibition

<table class="fixed-width table-group" id="tab1"><tr><td><table class="table"><colgroup><col style="width:11.25em"/><col style="width:1.77em"/><col style="width:5.90em"/><col style="width:15.47em"/></colgroup><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr class="thead"><td class="align_left">1</td><td class="align_center"> </td><td class="align_center">Cat #</td><td class="align_center">Sequence</td></tr><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr><td class="align_left">Flexitube siRNA PROM1</td><td class="align_center">1</td><td class="align_center">SI00083741</td><td class="align_center">CACGTTATAGTCCATGGTCCA</td></tr><tr><td class="align_left">Flexitube siRNA PROM1</td><td class="align_center">2</td><td class="align_center">SI00083748</td><td class="align_center">CAGGTAAGAACCCGGATCAAA</td></tr><tr><td class="align_left">Flexitube siRNA PROM1</td><td class="align_center">3</td><td class="align_center">SI00083755</td><td class="align_center">ACCTTTGAGTTTGGTCCCTAA</td></tr><tr><td class="align_left">Flexitube siRNA PROM1</td><td class="align_center">4</td><td class="align_center">SI03098263</td><td class="align_center">CTGGCTAAGTACTATCGTCGA</td></tr><tr class="table-tr"><td colspan="4"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Journal of Oncology

tab1

Table 1

Table 1: CD133 Is Associated with Increased Melanoma Cell Survival after Multikinase Inhibition 